Survival impact of lymph node dissection in endometrial adenocarcinoma: A surveillance, epidemiology, and end results analysis

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 255-261

  Smith, D C ^a   Macdonald, O K ^a   Lee, C M ^b   Gaffney, D K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Cancer Care Northwest ^*  (United States)

Author keywords

Adenocarcinoma; Endometrial cancer; Lymph node dissection; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; HEALTH CARE ORGANIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADENOCARCINOMA; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 40549135709     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01020.x     Document Type: Article

References (31)

1. FIGO. Annual report on the results of treatment in gynecologic cancer. Int J Gynaecol Obstet 1989 1989 : 189 93.
2. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005 106 : 413 25.
3. Girardi F, Petru E, Heydarfadai M et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993 49 : 177 80.
4. Larson DM, Johnson KK. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol 1993 51 : 345 8.
5. Ben-Shachar I, Pavelka J, Cohn DE et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005 105 : 487 93.
6. Lo KW, Cheung TH, Yu MY et al. The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 2003 13 : 863 9.
7. Chee JJ, Ho TH, Tay EH et al. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy. Ann Acad Med Singapore 2003 32 : 670 5.
8. Cragun JM, Havrilesky LJ, Calingaert B et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005 23 : 3668 75.
9. Mariani A, Webb MJ, Keeney GL et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000 182 : 1506 19.
10. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991 40 : 55 65.
11. Belinson JL, Lee KR, Badger GJ et al. Clinical stage I adenocarcinoma of the endometrium-analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992 44 : 17 23.
12. Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995 56 : 29 33.
13. Eltabbakh GH, Piver MS, Hempling RE et al. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997 38 : 373 80.
14. Ceccaroni M, Savelli L, Bovicelli A et al. Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. Anticancer Res 2004 24 : 2073 8.
15. Lutman CV, Havrilesky LJ, Cragun JM et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006 102 : 92 7.
16. Mariani A, Dowdy SC, Cliby WA et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 2006 101 : 200 8.
17. Mariani A, Keeney GL, Aletti G et al. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 2004 92 : 833 8.
18. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: incidence-SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying)-Linked To County Attributes. Total U.S., 1969-2003 Counties: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission, 2006.
19. Cox DR. Regression models and life tables. J R Stat Soc B 1972 34 : 187 220.
20. Roland PY, Kelly FJ, Kulwicki CY et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol 2004 93 : 125 30.
21. Macdonald OK, Sause WT, Lee RJ et al. Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol Oncol 2005 99 : 730 5. [Epub September 2005].
22. Macdonald OK, Sause WT, Lee RJ et al. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol 2006 22 : 22.
23. Lee CM, Szabo A, Shrieve DC et al. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. Jama 2006 295 : 389 97.
24. Aalders J, Abeler V, Kolstad P et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980 56 : 419 27.
25. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 2004 22 : 1234 41.
26. Havrilesky LJ, Cragun JM, Calingaert B et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005 99 : 689 95.
27. Kitchener H, Redman CW, Swart AM et al. ASTEC-a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Proceedings of the Society of Gynecologic Oncologists, 2006; 2006 Mar 22-26; Palm Springs, CA. [abstract].
28. Chan JK, Cheung MK, Huh WK et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 2006 107 : 1823 30.
29. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998 71 : 340 3.
30. Modesitt SC, Huang B, Shelton BJ et al. Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence. Gynecol Oncol 2006 103 : 300 6.
31. Jolly S, Vargas CE, Kumar T et al. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol Oncol 2006 103 : 87 93.